OMEROS CORP Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
OMEROS CORP (OMER) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -4.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-31
- OMEROS CORP effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -4.90%.
- OMEROS CORP effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -1.20%.
- OMEROS CORP effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -1.90%.
- OMEROS CORP effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -4.90% 10-K · filed 2026-03-31 | |
| 2024-12-31 | -1.20% 10-K · filed 2026-03-31 | 1.20% 10-K · filed 2025-03-31 |
| 2023-12-31 | -1.90% 10-K · filed 2026-03-31 | 1.90% 10-K · filed 2025-03-31 |
| 2022-12-31 | -0.20% 10-K · filed 2025-03-31 | 0.20% 10-K · filed 2023-03-13 |
| 2021-12-31 | -0.20% 10-K · filed 2024-04-01 | |
| 2020-12-31 | -0.10% 10-K · filed 2024-04-01 | 1.00% 10-K · filed 2021-03-01 |
| 2019-12-31 | -0.70% 10-K · filed 2022-03-01 | -1.00% 10-K · filed 2020-03-02 |
| 2018-12-31 | 0.10% 10-K · filed 2021-03-01 | 0.00% 10-K · filed 2019-03-01 |
| 2017-12-31 | 8.00% 10-K · filed 2020-03-02 | |
| 2016-12-31 | -3.00% 10-K · filed 2019-03-01 | 0.00% 10-K · filed 2017-03-16 |
| 2015-12-31 | 0.00% 10-K · filed 2018-03-01 | -1.00% 10-K · filed 2016-03-15 |
| 2014-12-31 | -1.00% 10-K · filed 2017-03-16 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-15 | |
| 2012-12-31 | 3.00% 10-K · filed 2015-03-16 | -3.00% 10-K · filed 2013-03-18 |
| 2011-12-31 | 0.00% 10-K · filed 2014-03-13 | |
| 2010-12-31 | 8.00% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |